Journals / Türk Biyokimya Dergisi / 2021 / Cilt: 46 - Sayı: 5

Endoplasmic reticulum stress in leukocytes from phenylketonuric patients

Pages
573–579
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: These results suggested that blood Phe concentrations might not be associated to ER stress in white blood cells obtained from the PKU patient groups under treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Phenylketonuria (PKU) is a proteinopathy due to the deficiency of phenylalanine hydroxylase (PAH) enzyme.
📊
Key Findings & Data:Methods: We primarily evaluated ER stress markers glucose-regulated protein78 (GRP78) and C/-EBP homolo- gous protein (CHOP), and thiobarbituric acid-reactive substances (TBARS) as a biomarker of oxidative stress in leukocytes and correlated it with blood Phe values from patients with PKU.
💡
Conclusion & Impact:Conclusions: These results suggested that blood Phe concentrations might not be associated to ER stress in white blood cells obtained from the PKU patient groups under treatment
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Phenylketonuria (PKU) is a proteinopathy due to the deficiency of phenylalanine hydroxylase (PAH) enzyme. The pathological elevation of phenylalanine (Phe) and its metabolites in PKU is linked to neurological hall- marks and mental disabilities. The aim of this study was to examine the hypothesis that high levels of Phe caused endoplasmic reticulum (ER) stress in PKU patients. Methods: We primarily evaluated ER stress markers glucose-regulated protein78 (GRP78) and C/-EBP homolo- gous protein (CHOP), and thiobarbituric acid-reactive substances (TBARS) as a biomarker of oxidative stress in leukocytes and correlated it with blood Phe values from patients with PKU. Patients in this study were selected from individuals who were diagnosed with PKU as a result of the national neonatal screening program and undergone treatment at our university hospital. The subjects were divided into four groups: healthy controls, patients with hyperphenylalaninemia (HPA), BH4 -responsive patients with PKU and patients with classic PKU. GRP78, CHOP and TBARS levels were estimated in leukocytes isolated from whole blood of subjects, Phe and tyrosine levels were determined in plasma. Results: The levels of Phe in BH 4-responsive PKU and classic PKU groups were statistically higher as compared to healthy controls, and Phe levels were higher in classic PKU compared to HPA group. CHOP levels were elevated by 35.3% in BH4 -responsive group compared to control. GRP78, CHOP and TBARS showed no statistical differences between control and patient groups. GRP78 was also negatively correlated with Phe levels. Conclusions: These results suggested that blood Phe concentrations might not be associated to ER stress in white blood cells obtained from the PKU patient groups under treatment

🔖

Cite This Article

AMANVERMEZ, R., BARDAK, K., ÖZER, I. (2021). Endoplasmic reticulum stress in leukocytes from phenylketonuric patients. Türk Biyokimya Dergisi, Cilt: 46 - Sayı: 5, 573–579. https://ajindex.com/articles/417162

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet 2010; 376:1417–27
  2. Schuck PF, Malgarin F, Cararo JH, Cardoso F, Streck EL, Ferreira GC. Phenylketonuria pathophysiology: on the role of metabolic alterations. Aging Dis 2015;6:390–9. 3. de la Parra A, Garcia MI, Waisbren SE, Cornejo V, Raimann E. Cognitive functioning in mild hyperphenylalaninemia. Mol Genet Metab Rep 2015;5:72–5
  3. Underhaug J, Aubi O, Martinez A. Phenylalanine hydroxylase misfolding and pharmacological chaperones. Curr Top Med Chem 2012;12:2534–45. 5. van Wegberk AMJ, McDonald A, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis 2017;12:162
  4. Strisciuglio P, Concolino D. New strategies for the treatment of phenylketonuria (PKU). Metabolites 2014;4:1007–17
  5. Muntau AC, Adams DJ, Belanger-Quintana A, Bushueva TV, Cerone R, Chien Y-H, et al. International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria. Mol Genet Metabol 2019;127:1–11
  6. Ghemrawi R, Battagli-Hsu SF, Arnold C. Endoplasmic reticulum stress in metabolic disorders. Cells 2018;7:63
  7. Lin JH, Walter P, Benedict Yen TS. Endoplasmic reticulum stress in disease pathogenesis. Ann Rev Pathol 2008;3:399–425
  8. Muneer A, Khan RMS. Endoplasmic reticulum stress: implications for neuropsychiatric disorders. Chonnam Med J 2019;55:8–19
  9. Maamoun H, Abdelsalam SS, Zeidan A, Korashy HM, Agouni A. Endoplasmic reticulum stress: a critical molecular driver of endothelial dysfunction and cardiovascular disturbances associated with diabetes. Int J Mol Sci 2019;20:1658–79
  10. Martinez-Pizarro A, Desviat LR, Ugarte M, Perez B, Richard E. Endoplasmic reticulum stress and autophagy in homocystinuria patients with remethylation defects. PLoS One 2016;11: e0150357
  11. Bergeron A, Jorquera R, Orejuela D, Tanguay RM. Involvement of endoplasmic reticulum stress in hereditary tyrosinemia type I. J Biol Chem 2006;281:5329–34
  12. Zhao L, Ackerman SL. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol 2006;18:444–52
  13. Zheng YZ, Cao ZG, Hu X, Shao ZM. The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancer. Breast Cancer Res Treat 2014;145:349–58
  14. Banuls C, Rovira-Liapis S, Lapez-Domenech S, Diaz-Morales N, Blas-Garcia A, Veses S, et al. Oxidative and endopl